Effectiveness of CoronaVac primary series with and without booster against hospitalized COVID-19 during the Omicron-predominant epidemic wave in the Philippines: a test-negative case–control study

Background CoronaVac (Sinovac) was initially effective against symptomatic COVID-19 and severe outcomes, but its performance against the immune-evasive Omicron variant remains uncertain. This study evaluated the effectiveness of CoronaVac against hospitalized COVID-19 among Filipino adults during th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kristal An Agrupis, Michelle Ylade, Yang Yang Qi, Maria Vinna Crisostomo, Jedas Veronica Daag, Gianne Lariz Magsakay, Jude Raphael Lo, Kiarah Louise Florendo, March Helena Jane Lopez, Jayne Marie Enriquez, Irish Lobitaña, Gretchen Bonita Ranada, Regina Alfonso, Mitzi Marie Chua, Mitzie Lou Osabel, Mary Ann Igoy-Bacay, Carren Anne Bocaling, Lorenz Von Seidlein, Xuanyi Wang, Jacqueline Deen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2025-12-01
coleção:	Expert Review of Vaccines
Assuntos:	COVID-19 CoronaVac Sinovac inactivated vaccines vaccine effectiveness SARS-CoV-2
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/14760584.2025.2539889
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!